Evaluation of histological grade and histologically tumour-free margins as predictors of local recurrence in completely excised canine mast cell tumours

被引:66
|
作者
Donnelly, L. [1 ]
Mullin, C. [1 ]
Balko, J. [1 ]
Goldschmidt, M. [1 ]
Krick, E. [1 ]
Hume, C. [1 ]
Brown, D. C. [1 ]
Sorenmo, K. [1 ]
机构
[1] Univ Penn, Sch Vet Med, Matthew J Ryan Vet Hosp, Philadelphia, PA 19104 USA
关键词
canine; grade; histologic margin; local recurrence; mast cell tumour; MOHS MICROGRAPHIC SURGERY; RADIATION-THERAPY; SURGICAL MARGINS; DOGS; EFFICACY; ASSOCIATION; SURVIVAL;
D O I
10.1111/vco.12021
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Completeness of mast cell tumour (MCT) excision is determined by assessment of histologically tumour-free margins (HTFM). The HTFM width necessary to prevent local recurrence (LR), recognized as histologic safety margin (HSM) in human oncology, has not been defined. We hypothesized that HTFM width would correlate with risk for LR and high-grade tumours would require wider HTFM than low-grade tumours. Records of dogs with completely excised MCTs were included. Signalment, two-tier tumour grade, tumour size, HTFM width, recurrence and therapy data was collected. High-grade (n=39) tumours were more likely to recur than low-grade (n=51) tumours (35.9% versus 3.9%), P<0.0001, with no association between HTFM width and LR. Twenty-nine percent of low-grade tumours had HTFM less than 3mm; none recurred. Narrow (3mm) histologic margins are likely adequate to prevent LR of low-grade tumours. High-grade tumours have significant risk of LR regardless of HTFM width.
引用
收藏
页码:70 / 76
页数:7
相关论文
共 10 条
  • [1] Vinblastine and prednisolone chemotherapy for surgically excised grade III canine cutaneous mast cell tumours
    Hayes, A.
    Adams, V.
    Smith, K.
    Maglennon, G.
    Murphy, S.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2007, 5 (03) : 168 - 176
  • [2] Patient and tumour factors influencing canine mast cell tumour histological grade and mitotic index
    Reynolds, Benjamin D.
    Thomson, Maurine J.
    O'Connell, Kathleen
    Morgan, Elizabeth J.
    Gummow, Bruce
    VETERINARY AND COMPARATIVE ONCOLOGY, 2019, 17 (03) : 338 - 344
  • [3] Epidemiological study of canine mast cell tumours according to the histological malignancy grade
    Smiech, A.
    Slaska, B.
    Lopuszynski, W.
    Jasik, A.
    Szczepanik, M.
    Wilkolek, P.
    POLISH JOURNAL OF VETERINARY SCIENCES, 2017, 20 (03): : 455 - 465
  • [4] Lomustine (CCNU) and prednisone chemotherapy for high-grade completely excised canine mast cell tumors
    Hay, Jennifer K.
    Larson, Victoria S.
    CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE, 2019, 60 (12): : 1326 - 1330
  • [5] Retrospective outcome evaluation for dogs with surgically excised, solitary Kiupel high-grade, cutaneous mast cell tumours
    Moore, Antony S.
    Frimberger, Angela E.
    Taylor, David
    Sullivan, Neill
    VETERINARY AND COMPARATIVE ONCOLOGY, 2020, 18 (03) : 402 - 408
  • [6] Histologically low-grade, yet biologically high-grade, canine cutaneous mast cell tumours: A systematic review and meta-analysis of individual participant data
    Bae, Sohee
    Milovancev, Milan
    Bartels, Courtney
    Irvin, Veronica L.
    Tuohy, Joanne L.
    Townsend, Katy L.
    Leeper, Haley
    VETERINARY AND COMPARATIVE ONCOLOGY, 2020, 18 (04) : 580 - 589
  • [7] Reassigned surgical margins after neoadjuvant chemotherapy results in low local recurrence in dogs with mast cell tumours
    Ciammaichella, Luca
    Sabattini, Silvia
    Del Magno, Sara
    Renzi, Andrea
    Cola, Veronica
    Zanardi, Stefano
    Agnoli, Chiara
    Marconato, Laura
    VETERINARY RECORD, 2024, 195 (06) : no
  • [8] Evaluation of Histological, Immunohistochemical, Clinical and Genetic Prognostic Factors Associated with the Response of Canine Mast Cell Tumours to Glucocorticotherapy
    dos Santos Horta, R.
    Eunice Lavalle, G.
    Narducci Monteiro, L.
    Alves dos Reis, F. B. T. M.
    de Padua Costa, M.
    Giuliano, A.
    Dantas Cassali, G.
    Dobson, J.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2018, 165 : 72 - 81
  • [9] Expression of Fibroblast Activating Protein and Correlation with Histological Grade, Mitotic Index and Ki67 Expression in Canine Mast Cell Tumours
    Giuliano, A.
    dos Santos Horta, R.
    Constantino-Casas, F.
    Hoather, T.
    Dobson, J.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2017, 156 (01) : 14 - 20
  • [10] Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012)
    Lejeune, A.
    Skorupski, K.
    Frazier, S.
    Vanhaezebrouck, I.
    Rebhun, R. B.
    Reilly, C. M.
    Rodriguez, C. O., Jr.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2015, 13 (03) : 267 - 280